Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Available 1Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 2NETWORK 1

Study Type

Interventional 2Expanded_access 1

Sponsor

Cancer Type

Sarcoma 3

Conditions

Osteosarcoma 3Neoplasms, Bone Tissue 1

Interventions

Cyclophosphamide 2067Radiotherapy 1990Cisplatin 1856Carboplatin 1560Gemcitabine 1454Paclitaxel 1320Bevacizumab 1320pembrolizumab 1238Docetaxel 1227Oxaliplatin 1184Capecitabine 1178Fluorouracil 1083Dexamethasone 979Magnetic Resonance Spectroscopy 971Nivolumab 936Rituximab 929Drug Therapy 915Surveys and Questionnaires 899Doxorubicin 845Etoposide 843Radiosurgery 816Blood Specimen Collection 816Irinotecan 784Cytarabine 743fludarabine 726Leucovorin 684Surgical Procedures, Operative 640Lenalidomide 618Biopsy 594fludarabine phosphate 569

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × mifamurtide × Clear all
NCT03643133 2026-05-19

SARCOME13

UNICANCER

Phase 2 Active not recruiting
60 enrolled
Sarcoma

Osteosarcoma, Neoplasms, Bone Tissue

NCT04571229 2026-05-11

Expanded Access Use of L-MTP-PE for the Treatment of Osteosarcoma

Memorial Sloan Kettering Cancer Center

Available
Sarcoma

Osteosarcoma

NCT02441309 2019-09-13

MEMOS

University of Oxford

Phase 2 Terminated
8 enrolled 17 charts
Sarcoma

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡